|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 225.5 EGP | 0.00% |
|
0.00% | +3.58% |
MINAPHARM Pharmaceuticals reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EGP 3,620.54 million compared to EGP 3,005.35 million a year ago. Net income was EGP 612.66 million compared to EGP 466.41 million a year ago.
Basic earnings per share from continuing operations was EGP 51.41 compared to EGP 36.42 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +3.58% | 52.08M | |
| +21.08% | 43.34B | |
| +20.44% | 21.96B | |
| +11.49% | 14.09B | |
| +13.09% | 13.64B | |
| +38.86% | 11.43B | |
| -8.59% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +8.46% | 5.22B |
MINAPHARM PHARMACEUTICALS 
